[
    [
        {
            "time": "",
            "original_text": "抗肿瘍新药行业专题系列2：血癌篇：三大靶向新品层出 CAR-T疗法蓄势待发",
            "features": {
                "keywords": [
                    "抗肿瘤",
                    "新药",
                    "血癌",
                    "靶向治疗",
                    "CAR-T疗法"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "抗肿瘍新药行业专题系列2：血癌篇：三大靶向新品层出 CAR-T疗法蓄势待发",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "复星医药子公司YP01001胶囊获批开展针对晚期实体瘤的临床试验",
            "features": {
                "keywords": [
                    "复星医药",
                    "YP01001胶囊",
                    "临床试验",
                    "晚期实体瘤"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "复星医药子公司YP01001胶囊获批开展针对晚期实体瘤的临床试验",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]